Paul OConnell - Vascular Solutions Insider

Vascular Solutions Inc -- USA Stock  

USD 56.00  0.00  0.00%

Independent Director

Mr. Paul OConnell is an Independent Director of Vascular Solutions, Inc., since January 29, 2002. He In January of 2014, Mr. OConnell became President of B. Braun CeGat, a genomic sequencing and diagnostic company providing services to clinicians and hospitals in the United States. Since 2001, Mr. OConnell has also been serving as President of B. Braun Interventional Systems, Inc., a wholly owned subsidiary of B. Braun Melsungen AG, a global supplier of products for anesthesia, intensive medicine, cardiology, extra corporeal blood treatment and surgery as well as services for hospitals, general practitioners and the homecare sector. Mr. OConnell was previously Vice President of the Vascular Interventional Products Group of B. Braun Medical, an international medical device company, from 1989 to 2001. In addition, from 1999 through 2001, Mr. OConnell provided marketing and technical support consulting services to medical device companies. Mr. OConnell was the owner of Sablier, a medical device company, from 1998 through 1999 where he developed new technologies for the treatment of thromboembolic diseases and for distal protection during carotid endarterectomy. From 1993 through 1998, Mr. OConnell was Vice President and General Manager of the Vena Tech division of B. Braun Medical, a medical device business he originally cofounded in 1988 and sold to B. Braun Medical in 1993. Through more than 20 years of experience as the General Manager or President of growthoriented medical device companies within cardiology and radiology fields of practice,
Age: 61  Director Since 2002      
877 656-4251

Paul OConnell Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 6.28 % which means that it generated profit of $6.28 on every $100 spent on asset. This is normal as compared to the sector avarege.
The company currently holds 867 K in liabilities with Debt to Equity (D/E) ratio of 0.13 which may suggest the company is not taking enough advantage from borrowing. Vascular Solutions Inc has Current Ratio of 6.24 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


John SaywardDigirad Corporation
Allen KamerDarioHealth Corp
Martha MarshEdwards Lifesciences Corporatio
Craig WalkerEndoChoice Holdings Inc
Charles GillmanDigirad Corporation
Rami YehudihaDarioHealth Corp
Yossi BahagonDarioHealth Corp
David MowryEndoChoice Holdings Inc
John CardisEdwards Lifesciences Corporatio
Michael CunnionDigirad Corporation
Dimitrios AngelisDigirad Corporation
Michael BallangerEndoChoice Holdings Inc
Uri GeigerEndoChoice Holdings Inc
John SmythEndoChoice Holdings Inc
Scott DavisEndoChoice Holdings Inc
Scott CarterEndoChoice Holdings Inc
Nicholas ValerianiEdwards Lifesciences Corporatio
Barbara McNeilEdwards Lifesciences Corporatio
James BalkcomEndoChoice Holdings Inc
John ClimacoDigirad Corporation
Eric SchjelderupEndoChoice Holdings Inc

Entity Summary

Vascular Solutions, Inc., a medical device company, offer clinical solutions for treating coronary and peripheral vascular disease worldwide. Vascular Solutions Inc (VASC) is traded on NASDAQ in USA. It is located in MINNESOTA, U.S.A and employs 568 people. Vascular Solutions is listed under Medical Equipment category by Fama And French industry classification.

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Vascular Solutions Inc to your portfolio

Top Management

Vascular Solutions Inc Leadership Team

Stock Performance

Vascular Solutions Performance Indicators